trending Market Intelligence /marketintelligence/en/news-insights/trending/Jmuk3aE8_zGruqSy8o_LvQ2 content esgSubNav
In This List

ArQule raises $15.7M through private placement

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


ArQule raises $15.7M through private placement

ArQule Inc. raised $15.7 million after selling 13,938,651 shares of the company to certain investors, including BVF Partners LP.

The investors also received warrants to purchase up to an additional 3,123,674 shares of the company at $1.75 apiece.

ArQule intends to use the net proceeds to advance clinical trials of its proprietary pipeline, including derazantinib, ARQ 092, ARQ 531 and ARQ 751.